In a major shift within the retail industry, Walgreens Boots Alliance (WBA), one of America’s most recognized companies, has agreed to be sold to private equity firm Sycamore Partners in a deal valued at approximately $10 billion. The acquisition marks the conclusion of Walgreens 98 year holding as a publicly traded company, having been listed since 1927.
Sycamore Partners will purchase WBA at $11.45 per share, reflecting a 29% premium over the company’s stock price on December 9th, 2024, the day before the exposure of the acquisition. Shareholders stand to receive up to an extra $3 per share contingent upon the future sale of WBA units, potentially elevating the total transaction value, inclusive of debt and prospective payouts, to nearly $24 billion.
The decision to transition WBA into private ownership aimed at facilitating a comprehensive restructuring away from the immediate pressure of public market expectations. CEO Tim Wentworth acknowledged the necessity for focused transformation, stating that such significant changes are “better managed as a private company.”
WBA has been confronting several challenges, including diminishing prescription reimbursements, escalating operational costs, and a consumer shift towards alternative retail options. In response, the company has initiated plans to close approximately 1200 underperforming US stores over the next three years and is evaluating the potential divestiture of its VillageMD clinic business.
The acquisition notably employs an aggressive financing strategy, with Sycamore partners planning to fund roughly 83% of the deal through debt. This leverage ratio significantly exceeds the average debt level in private equity acquisitions, which stood at 41% in the previous year.
Following the completion and shareholder approvals, the transaction is expected to be finalized in the fourth quarter of 2025, after which Walgreens Boots Alliance will transition to private ownership. The company intends to preserve its core brands, including Walgreens and Boots, and will continue to operate from its Chicago headquarters.
This strategic transition is designed to provide Walgreens Boots Alliance with increased flexibility, incentivizing the company to restructure from the pressure from public markets.
Sycamore Partners’ move could set a precedent for future private equity investments targeting brick-and-mortar businesses. As consumer behavior continues to evolve, many other retailers may increasingly find themselves attractive targets for private equity firms seeking value through restructuring and strategic reinvention. Ultimately, this shift aims to strengthen WBA’s standing within the retail pharmacy industry.